Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dekavil + MTX in Rheumatoid Arthritis
NCT02076659Phase 1Completed
- Sponsor
- Philogen
- Start
- Sep 2011
- Primary completion
- Apr 2017
- Modality
- Antibody Conjugates, Cytokines & Interferons, Engineered Antibody Formats
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of f8il10 in rheumatoid arthritis (RA) (3 arms), sponsored by Philogen. Primary endpoint: Dose Limiting Toxicities. Started Sep 2011; status: completed.
02
Drugs
f8il10
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02076659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02076659.